Parkinson's Disease Flashcards

1
Q

What is Parkinson’s disease?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is PD often left undiagnosed & untreated?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline some PD statistics.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the four cardinal signs and symptoms of PD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Outline the characteristic problems of PD.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline the epidemiology of PD

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parkinson’s disease is a result of…

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the Substantia Nigra?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is it called the Substantia Nigra?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two parts of the substantia nigra & their function?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of the Nigrostriatal pathway?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the function of the Putamen and Caudate nuclei?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the two types of medium-sized spiny GABAergic neurons?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the imbalance of the motor circuitry mean?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why & how are Lewy bodies important in PD?/

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Outline PET imaging techniques for PD.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain the pathophysiology of PD.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outline the normal dopamine pathway vs PD dopamine pathway

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why is an abnormal protein build-up a problem in PD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the progression of neurofunction loss in neurodegenerative disorders

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pathophysiology of PD: Degeneration of Nigrostriatal Pathway

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How do we diagnose PD? /Steps?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the motor signs and symptoms of PD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the nonmotor signs and symptoms of PD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

State the differential diagnosis of PD.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the Gold Standard of treatment?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the therapeutic challenge for L-DOPA?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the symptoms reduced by Levodopa?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Why is Levodopa effective at eliminating postural instability & shuffling gait?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the problems of Levodopa?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Outline the MOA of Levodopa?

A
32
Q

What is the difference between noradrenergic and dopaminergic neurons?

A
33
Q

What happens if we have more dopa decarboxylase?

A
34
Q

Why is L-DOPA the cornerstone of PD therapy?

A
35
Q

What are the two forms of L-DOPA?

A
36
Q

Sinemet/Co-careldopa

A
37
Q

Madopar/Co-beneldopa

A
38
Q

Why is L-DOPA used alongside peripheral dopa decarboxylase inhibitors?

A
39
Q

What are some additional issues with L-DOPA?

A
40
Q

What should Pharmacists do if patients develop an impulse control disorder?

A
41
Q

What is the current challenge in the treatment of PD?

A
42
Q

How does levodopa therapy reduce morbidity/mortality in PD?

A
43
Q

Describe the progress in the Pharmacotherapy of the symptoms of PD

A
44
Q

What are the two types of dopamine agonists?

A
45
Q

MOA of COMT Inhibitors?

A
46
Q

MOA of MAO-B inhibitors?

A
47
Q

How do these PD drugs work/site of action?

A
48
Q

What are the main features of Dopamine agonists?

A
49
Q

What are the Side effects of Dopamine agonists?

A
50
Q

Give examples of Dopamine agonists/synthetic dopamine

A
51
Q

What is the main issue with Dopamine agonists?

A
52
Q

Outline Ergot agonist dosing examples

A
53
Q

Outline Non-ergot agonist dosing examples

A
54
Q

What are the two types of Monoamine oxidase?

A
55
Q

MAO-A

A
56
Q

MAO-B

A
57
Q
  • What is the role of Monoamine oxidase?
A
58
Q

What are the features of Catechol-O-Methyl transferase (COMT)

A
59
Q

How does Entacapone improve L-DOPA pharmacokinetics and Efficacy?

A
60
Q

What is the effect of combing L-DOPA with Entacapone?

A
61
Q

What is the effect of Entacapone on L-DOPA availability in the brain?

A
62
Q

What are the problems with current treatment strategies?

A
63
Q

What are the most important motor complications for Parkinson’s disease treatment?

A
64
Q

Give examples of Antiparkinsonian agents used to treat motor fluctuations.

A
65
Q

Why are there symptoms of re-emergence when Levodopa plasma levels fall?

A
66
Q

What is Levodopa-induced dyskinesia?

A
67
Q

What drug can control Levodopa-induced dyskinesia?

A
68
Q

Features of Amantadine

A
69
Q

What are the side effects of Amantadine?

A
70
Q

Livedo reticularis

A
71
Q

What are other problems with Amantadine?

A
72
Q

Why is PD described as a multi-system disease?

A
73
Q

What are the neuropsychiatric problems in PD?

A
74
Q

What are the non-motor symptoms in PD?

A
75
Q

How do non-motor symptoms help to identify motor symptoms?

A
76
Q

Medication profile for PD drugs

A